Aligos Therapeutics, Inc. (ALGS) vs MIRA Pharmaceuticals, Inc. (MIRA)

A side-by-side comparison of Aligos Therapeutics, Inc. and MIRA Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGS vs MIRA

growth of $100 · dividends reinvested · last 3y
ALGS -77.6% (-39.3%/yr)MIRA -88.5% (-51.4%/yr)ALGS compounded faster over this window
050100150200Start $100202420252026$22$11
ALGS MIRA

ALGS vs MIRA: by the numbers

  • •ALGS is the larger company ($33M vs $30M market cap).
  • •Both run net losses; MIRA's is the smaller (0.00% vs -241.01% net margin).

Metrics side by side

Valuation

MetricALGSMIRA
P/S ratio1.06N/A
P/B ratio1.043.66

Profitability

MetricALGSMIRA
Gross margin57.46%0.00%
Operating margin-4024.93%0.00%
Net margin-241.01%0.00%
ROE-238.24%-116.14%
ROIC-207.97%-115.18%

Growth (annualized)

MetricALGSMIRA
Revenue CAGR (5Y)-15.85%N/A
Total return CAGR (5Y)-57.15%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.